Indian Pharmaceutical companies, from Sun Pharma Ltd., to Lupin Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd., Gland Pharma Ltd., will be reacting on Wednesday, April 9, after US President Donald Trump said that he will be announcing major tariffs on the Pharma sector soon. Speaking at the Republican NRCC event, Trump said that major […]
Pharma Stocks Crash: Donald Trump says tariffs will be at ‘never seen before’ levels – CNBC TV18
Shares of Indian Pharma Companies, Aurobindo Pharma, IPCA Laboratories, Lupin and others fell up to 5% on Friday, April 4, after US President Donald Trump remarked about the upcoming tariffs on the sector. “Pharma tariffs are going to come in at levels you have never seen before. We are looking at pharmaceuticals as a separate […]
Trump Reciprocal Tariffs: These Indian Pharma companies are likely to be impacted – CNBC TV18
April 2 is the day that Donald Trump’s proposed reciprocal tariffs kick in, even as the world awaits an official announcement on the scope and quantum of tariffs from the US President. A sector in the line of fire is Pharma, as majority of Indian Pharma exports head to the US. However, the White House […]
Gland Pharma’s Visakhapatnam facility gets 3 observations after USFDA inspection – CNBC TV18
Gland Pharma Ltd on Tuesday (February 25) announced that America’s drug regulatory watchdog has completed a crucial inspection of its Andhra Pradesh facility. Company Value Change %Change In a regulatory filing, Gland Pharma said, “…the United States Food and Drug Administration (USFDA) has conducted a pre-approval inspection (PAI) for Sterile APIs at the company’s Facility […]
Gland Pharma Q3 Results | Net profit, margin up; revenue dips 10% – CNBC TV18
Drug firm Gland Pharma Ltd on Monday (February 3) reported a 6.7% year-on-year (YoY) increase in net profit at ₹204.7 crore for the third quarter that ended December 31, 2024. In the corresponding quarter of the previous fiscal, the company posted a net profit of ₹191.9 crore. Company Value Change %Change Revenue from operations fell […]
Marketbuzz Podcast With Hormaz Fatakia: Nifty looks to end final expiry of 2024 on a high on low volumes – CNBC TV18
Company Value Change %Change Hello and Welcome to the Marketbuzz Podcast on CNBC-TV18. Lets bring you up to speed with everything you need to be aware of before the day’s trading action. Nifty continues to remain in a range Final expiry of 2024 to be dominated by low volumes 200-DMA remains a […]
Gland Pharma unit receives 10 observations from French drug regulator – CNBC TV18
Gland Pharma Ltd. on Wednesday, December 25, said the French drug regulator ANSM has issued 10 observations to its material subsidiary, Cenexi’s Fontenay Manufacturing Facility. Company Value Change %Change The pharma company, in a stock exchange filing, stated that the Agence nationale de sécurité du médicament et des produits de santé (ANSM), France, conducted good […]
Trade Setup for December 12: Will the Nifty weekly expiry breathe life back into the index? – CNBC TV18
Its been nearly a week since the Nifty is stuck in this 300-point range between its 50 and 100-Day Moving Average. It does not come as a surprise either, as barring that 50 basis points CRR cut on Friday, most of the commentary from the Reserve Bank of India erred on the side of caution. […]
Gland Pharma shares jump 11% post Q2 results; Kotak upgrades on limited downside risk – CNBC TV18
Shares of Gland Pharma Ltd. were trading with gains of up to 10% on Tuesday, November 5. The stock has corrected 24% over the past three months and delivered flat returns over the past year, compared to a 50% gain for Nifty Pharma, which Kotak Institutional Equities believes limits further downside. Accordingly, the brokerage firm […]
Goldman Sachs expects Gland Pharma shares to fall back to their IPO price – CNBC TV18
Brokerage firm Goldman Sachs has downgraded shares of Gland Pharma to “sell” from its earlier rating of “buy”. The brokerage has also cut its price target by 27% to ₹1,500 from ₹2,075 earlier. In fact, Goldman Sachs’ price target is exactly the IPO price of Gland Pharma when it made its street debut in 2020. […]